Abnova (4133) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 亞諾法

Abnova (4133) reported revenue of NT$31.9 million for Oct 2026, +19.1% year on year and +30.8% from the previous month. Revenue for Jan–Oct 2026 was NT$285.6 million (-2.9% year on year).

In Oct 2026, it ranked No. 117 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$28.3 million24/10Nov 2024 NT$31.4 millionDec 2024 NT$28.3 millionJan 2025 NT$22.9 millionFeb 2025 NT$31.8 million25/02Mar 2025 NT$35.9 millionApr 2025 NT$30.5 millionMay 2025 NT$29.7 millionJun 2025 NT$31.3 million25/06Jul 2025 NT$28 millionAug 2025 NT$31.3 millionSep 2025 NT$26 millionOct 2025 NT$26.8 million25/10Nov 2025 NT$29.6 millionDec 2025 NT$27.5 millionJan 2026 NT$25.7 millionFeb 2026 NT$27.8 million26/02Mar 2026 NT$34.4 millionApr 2026 NT$29.1 millionMay 2026 NT$29.9 millionJun 2026 NT$29.3 million26/06Jul 2026 NT$26.3 millionAug 2026 NT$26.7 millionSep 2026 NT$24.4 millionOct 2026 NT$31.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$31.9 million+19.1%+30.8%
Sep 2026NT$24.4 million-5.9%-8.7%
Aug 2026NT$26.7 million-14.7%+1.6%
Jul 2026NT$26.3 million-6.0%-10.3%
Jun 2026NT$29.3 million-6.4%-1.8%
May 2026NT$29.9 million+0.5%+2.7%
Apr 2026NT$29.1 million-4.6%-15.4%
Mar 2026NT$34.4 million-4.1%+23.7%
Feb 2026NT$27.8 million-12.4%+8.2%
Jan 2026NT$25.7 million+12.4%-6.5%
Dec 2025NT$27.5 million-3.0%-7.3%
Nov 2025NT$29.6 million-5.7%+10.6%
Oct 2025NT$26.8 million-5.2%+3.3%
Sep 2025NT$26 million-5.5%-17.2%
Aug 2025NT$31.3 million-5.3%+11.9%
Jul 2025NT$28 million-6.3%-10.7%
Jun 2025NT$31.3 million+12.2%+5.4%
May 2025NT$29.7 million-1.9%-2.5%
Apr 2025NT$30.5 million-9.0%-15.0%
Mar 2025NT$35.9 million+13.5%+13.0%
Feb 2025NT$31.8 million+20.7%+38.9%
Jan 2025NT$22.9 million-15.6%-19.3%
Dec 2024NT$28.3 million+5.8%-9.8%
Nov 2024NT$31.4 million-4.0%+11.1%
Oct 2024NT$28.3 million-18.0%+3.0%

Jan–Oct 2026 cumulative: NT$285.6 million (-2.9% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Abnova vs PEC / Abnova vs Lotus Pharm / Abnova vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16